AnaptysBio, Inc.: insider trading
325 trades by 26 directors, officers and 10% owners since 2017, from their SEC Form 4 and 5 filings.
Bought, 12 months
$17.2 M
3 purchases by 1 insider
Sold, 12 months
$9.8 M
42 sales by 8 insiders
Bought, 3 months
$17.2 M
3 purchases
Sold, 3 months
$249 K
1 sale
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (26)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| EcoR1 Capital, LLCDirector, 10% owner | — | $17.2 M | — | |
| Hollings RentonDirector | 10,995 | — | $249 K | |
| John A. OrwinDirector | 17,995 | — | — | |
| John P. SchmidDirector | 37,652 | — | $1.2 M | |
| Daniel FagaPresident, CEO, Director | 495,965 | — | $2.8 M | |
| Eric J. LoumeauCHIEF LEGAL OFFICER | 12,835 | — | $2.7 M | |
| Magda MarquetDirector | 9,930 | — | $531 K | |
| Dennis MulroyCHIEF FINANCIAL OFFICER | 21,852 | — | $1.5 M | |
| Paul F. LizzulChief Medical Officer | 42,088 | — | $522 K | |
| J. Anthony WareDirector | 9,630 | — | $193 K | |
| Dennis M. FentonDirector | 4,965 | — | — | |
| Rita JainDirector | 11,864 | — | — | |
| Hamza SuriaPresident, CEO, Director | 68,600 | — | — | |
| Oleg NodelmanDirector, 10% owner | — | — | — | |
| James N. TopperDirector | 80,812 | — | — | |
| Marco LondeiChief Medical Officer | 68,579 | — | — | |
| Dominic PiscitelliChief Financial Officer | 0 | — | — | |
| Nader J. Naini10% owner | 973,612 | — | — | |
| Nicholas LydonDirector | 271,106 | — | — | |
| Novo Holdings A/S10% owner | 1.94 M | — | — | |
| Stephen Lawrence Tomlin10% owner | — | — | — | |
| Alan D. Frazier10% owner | 2.35 M | — | — | |
| Nathan R. Every10% owner | — | — | — | |
| A/s Novo10% owner | 3.03 M | — | — | |
| Carol Giltner GallagherDirector | 64,296 | — | — | |
| Patrick J. Heron10% owner | 311,291 | — | — |
Trades#
The newest 300 trades.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | EcoR1 Capital, LLCDirector, 10% owner | Buyindirect | +138,093 | $46.54 | $6.4 M | 8.25 M | Form 4 |
| filed | EcoR1 Capital, LLCDirector, 10% owner | Buyindirect | +152,367 | $45.66 | $7.0 M | 8.12 M | Form 4 |
| filed | EcoR1 Capital, LLCDirector, 10% owner | Buyindirect | +84,120 | $45.66 | $3.8 M | 7.96 M | Form 4 |
| filed | Hollings RentonDirector | Option exercise10b5-1 plan | +5,000 | $18.03 | $90 K | 15,995 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -5,000 | $49.87 | $249 K | 10,995 | Form 4 |
| filed | John A. OrwinDirector | Option exercise | +1,300 | — | — | 17,995 | Form 4 |
| filed | John P. SchmidDirector | Option exercise | +6,030 | — | — | 37,652 | Form 4 |
| filed | Hollings RentonDirector | Option exercise | +6,030 | — | — | 10,995 | Form 4 |
| filed | John A. OrwinDirector | Option exercise | +6,030 | — | — | 16,695 | Form 4 |
| filed | John P. SchmidDirector | Sell | -12,596 | $55.71 | $702 K | 39,671 | Form 4 |
| filed | John P. SchmidDirector | Sell | -7,527 | $56.70 | $427 K | 32,144 | Form 4 |
| filed | John P. SchmidDirector | Sell | -522 | $57.40 | $30 K | 31,622 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -510 | $56.61 | $29 K | 513,134 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -2,570 | $57.91 | $149 K | 510,564 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -3,662 | $58.62 | $215 K | 506,902 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -490 | $59.62 | $29 K | 506,412 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -550 | $60.63 | $33 K | 505,862 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -1,012 | $62.15 | $63 K | 504,850 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -2,592 | $63.35 | $164 K | 502,258 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -3,155 | $64.19 | $203 K | 499,103 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -3,038 | $65.20 | $198 K | 496,065 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -100 | $65.99 | $7 K | 495,965 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Grant or award | +34,300 | — | — | 513,644 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +10,000 | $29.70 | $297 K | 22,835 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -10,000 | $54.00 | $540 K | 12,835 | Form 4 |
| filed | Magda MarquetDirector | Option exercise | +11,000 | $26.11 | $287 K | 20,930 | Form 4 |
| filed | Magda MarquetDirector | Sell | -9,290 | $48.12 | $447 K | 11,640 | Form 4 |
| filed | Magda MarquetDirector | Sell | -1,710 | $48.85 | $84 K | 9,930 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell | -2,210 | $44.71 | $99 K | 12,835 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell | -3,650 | $44.71 | $163 K | 42,088 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell | -2,515 | $44.71 | $112 K | 21,852 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -14,281 | $44.71 | $639 K | 479,344 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Option exercise | +26,838 | — | — | 493,625 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise | +8,525 | — | — | 45,738 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise | +6,700 | — | — | 24,367 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise | +5,888 | — | — | 15,045 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell | -2,017 | $45.11 | $91 K | 16,779 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell | -2,235 | $45.11 | $101 K | 37,213 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -9,202 | $45.11 | $415 K | 466,787 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell | -1,908 | $45.11 | $86 K | 17,667 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -5,281 | $45.38 | $240 K | 11,498 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -1,841 | $46.13 | $85 K | 9,657 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -500 | $47.23 | $24 K | 9,157 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise | +6,145 | — | — | 39,448 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Option exercise | +17,850 | — | — | 475,989 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise | +5,245 | — | — | 19,575 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise | +5,545 | — | — | 18,796 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell | -3,363 | $43.26 | $145 K | 14,330 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell | -4,219 | $43.26 | $183 K | 33,303 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Sell | -15,309 | $43.26 | $662 K | 458,139 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell | -2,983 | $43.26 | $129 K | 13,251 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise | +10,555 | — | — | 37,522 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise | +8,292 | — | — | 17,693 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Option exercise | +34,677 | — | — | 473,448 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise | +7,287 | — | — | 16,234 | Form 4 |
| filed | John P. SchmidDirector | Otherindirect | -11,068 | $51.00 | $564 K | 0 | Form 4 |
| filed | J. Anthony WareDirector | Sell | -3,900 | $49.58 | $193 K | 9,630 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise10b5-1 plan | +10,000 | $20.16 | $202 K | 19,401 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +10,000 | $14.02 | $140 K | 18,947 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise10b5-1 plan | +1,500 | $18.50 | $28 K | 28,467 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -10,000 | $51.00 | $510 K | 8,947 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell10b5-1 plan | -10,000 | $50.00 | $500 K | 9,401 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell10b5-1 plan | -1,500 | $50.00 | $75 K | 26,967 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -141 | $46.99 | $7 K | 8,947 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +10,000 | $14.02 | $140 K | 19,088 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -10,000 | $46.00 | $460 K | 9,088 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise10b5-1 plan | +10,000 | $20.16 | $202 K | 25,126 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +5,000 | $14.02 | $70 K | 14,088 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell10b5-1 plan | -9,365 | $44.62 | $418 K | 15,761 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +7,500 | $20.16 | $151 K | 21,588 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell10b5-1 plan | -6,360 | $45.21 | $288 K | 9,401 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -8,305 | $44.68 | $371 K | 13,283 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -4,195 | $45.24 | $190 K | 9,088 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +5,000 | $14.02 | $70 K | 17,328 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -8,240 | $29.00 | $239 K | 9,088 | Form 4 |
| filed | John A. OrwinDirector | Option exercise | +1,300 | — | — | 10,665 | Form 4 |
| filed | Hollings RentonDirector | Option exercise10b5-1 plan | +10,231 | $6.930 | $71 K | 15,196 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -3,110 | $19.44 | $60 K | 12,086 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -7,121 | $19.70 | $140 K | 4,965 | Form 4 |
| filed | Hollings RentonDirector | Option exercise10b5-1 plan | +20,925 | $6.930 | $145 K | 25,890 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -7,250 | $23.09 | $167 K | 18,640 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -13,675 | $23.82 | $326 K | 4,965 | Form 4 |
| filed | Dennis M. FentonDirector | Sell10b5-1 plan | -3,015 | $23.97 | — | 4,965 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -3,015 | $23.97 | $72 K | 4,965 | Form 4 |
| filed | Magda MarquetDirector | Option exercise | +6,030 | — | — | 9,930 | Form 4 |
| filed | Hollings RentonDirector | Option exercise | +6,030 | — | — | 7,980 | Form 4 |
| filed | John P. SchmidDirector | Option exercise | +6,030 | — | — | 52,267 | Form 4 |
| filed | John A. OrwinDirector | Option exercise | +6,030 | — | — | 9,365 | Form 4 |
| filed | Dennis M. FentonDirector | Option exercise | +6,030 | — | — | 7,980 | Form 4 |
| filed | J. Anthony WareDirector | Option exercise | +6,030 | — | — | 13,530 | Form 4 |
| filed | Rita JainDirector | Option exercise | +7,330 | — | — | 11,864 | Form 4 |
| filed | John P. SchmidDirector | Otherindirect | +11,068 | $18.18 | $201 K | 11,068 | Form 4 |
| filed | John P. SchmidDirector | Option exercise | +21,692 | $4.550 | $99 K | 25,592 | Form 4 |
| filed | John P. SchmidDirector | Option exercise | +20,645 | $8.540 | $176 K | 46,237 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Option exercise | +17,850 | — | — | 442,853 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise | +5,545 | — | — | 13,220 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise | +6,145 | — | — | 27,904 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise | +5,245 | — | — | 15,856 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Shares withheld for tax | -2,054 | $15.30 | $31 K | 13,802 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Shares withheld for tax | -6,387 | $15.30 | $98 K | 436,466 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Shares withheld for tax | -2,261 | $15.30 | $35 K | 25,643 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Shares withheld for tax | -2,217 | $15.30 | $34 K | 11,003 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Option exercise | +34,678 | — | — | 438,036 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise | +7,288 | — | — | 10,669 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise | +10,555 | — | — | 26,095 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise | +8,293 | — | — | 14,018 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Shares withheld for tax | -3,407 | $14.60 | $50 K | 10,611 | Form 4 |
| filed | Daniel FagaPresident, CEO, Director | Shares withheld for tax | -13,033 | $14.60 | $190 K | 425,003 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Shares withheld for tax | -4,336 | $14.60 | $63 K | 21,759 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Shares withheld for tax | -2,994 | $14.60 | $44 K | 7,675 | Form 4 |
| filed | EcoR1 Capital, LLCDirector, 10% owner | Buyindirect | +6,646 | $12.95 | $86 K | 7.88 M | Form 4 |
| filed | EcoR1 Capital, LLCDirector, 10% owner | Buyindirect | +13,268 | $12.93 | $172 K | 7.87 M | Form 4 |
| filed | EcoR1 Capital, LLCDirector, 10% owner | Buyindirect | +65,184 | $12.92 | $842 K | 7.86 M | Form 4 |
| filed | Hollings RentonDirector | Option exercise10b5-1 plan | +10,000 | $6.930 | $69 K | 11,950 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -10,000 | $25.00 | $250 K | 1,950 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise10b5-1 plan | +1,500 | $18.50 | $28 K | 16,898 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell10b5-1 plan | -1,500 | $38.67 | $58 K | 15,398 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -3,780 | $38.41 | $145 K | 3,240 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell10b5-1 plan | -2,220 | $38.93 | $86 K | 4,744 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell10b5-1 plan | -2,220 | $38.93 | — | 15,398 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -2,220 | $38.93 | — | 8,520 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +5,000 | $14.02 | $70 K | 13,520 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise10b5-1 plan | +10,000 | $20.16 | $202 K | 14,744 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell10b5-1 plan | -10,000 | $40.13 | $401 K | 4,744 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -6,500 | $40.13 | $261 K | 7,020 | Form 4 |
| filed | John A. OrwinDirector | Option exercise | +1,300 | — | — | 3,335 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise10b5-1 plan | +6,000 | — | — | 17,618 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Option exercise10b5-1 plan | +6,000 | — | — | 6,964 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +6,000 | — | — | 10,740 | Form 4 |
| filed | EcoR1 Capital, LLC10% owner | Buyindirect | +273,972 | $36.50 | $10.0 M | 7.79 M | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise10b5-1 plan | +2,000 | $18.50 | $37 K | 13,618 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell10b5-1 plan | -2,000 | $40.00 | $80 K | 11,618 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise10b5-1 plan | +1,500 | $18.50 | $28 K | 13,118 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell10b5-1 plan | -1,500 | $35.00 | $53 K | 11,618 | Form 4 |
| filed | Hollings RentonDirector | Option exercise10b5-1 plan | +10,000 | $6.930 | $69 K | 11,950 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -7,103 | $30.50 | $217 K | 4,847 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -2,897 | $30.98 | $90 K | 1,950 | Form 4 |
| filed | Dennis M. FentonDirector | Sell10b5-1 plan | -1,950 | $23.17 | $45 K | 1,950 | Form 4 |
| filed | Hollings RentonDirector | Sell10b5-1 plan | -1,950 | $23.16 | $45 K | 1,950 | Form 4 |
| filed | Magda MarquetDirector | Option exercise | +3,900 | — | — | 3,900 | Form 4 |
| filed | J. Anthony WareDirector | Option exercise | +3,900 | — | — | 7,500 | Form 4 |
| filed | Hollings RentonDirector | Option exercise | +3,900 | — | — | 3,900 | Form 4 |
| filed | John A. OrwinDirector | Option exercise | +2,035 | — | — | 2,035 | Form 4 |
| filed | Rita JainDirector | Option exercise | +4,534 | — | — | 4,534 | Form 4 |
| filed | John P. SchmidDirector | Option exercise | +3,900 | — | — | 3,900 | Form 4 |
| filed | Dennis M. FentonDirector | Option exercise | +3,900 | — | — | 3,900 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell10b5-1 plan | -1,500 | $23.72 | $36 K | 964 | Form 4 |
| filed | Daniel FagaCEO, Director | Shares withheld for tax | -347,441 | $21.60 | $7.5 M | 401,646 | Form 4 |
| filed | Daniel FagaCEO, Director | Sell | -3,000 | $21.42 | $64 K | 749,087 | Form 4 |
| filed | Daniel FagaCEO, Director | Sell | -145,940 | $22.78 | $3.3 M | 752,087 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Option exercise10b5-1 plan | +5,000 | $14.02 | $70 K | 8,240 | Form 4 |
| filed | Eric J. LoumeauCHIEF LEGAL OFFICER | Sell10b5-1 plan | -5,000 | $25.00 | $125 K | 3,240 | Form 4 |
| filed | Dennis MulroyCHIEF FINANCIAL OFFICER | Sell10b5-1 plan | -3,065 | $23.63 | $72 K | 964 | Form 4 |
| filed | Dennis MulroyChief Financial Officer | Sell | -2,180 | $21.81 | $48 K | 4,029 | Form 4 |
| filed | Eric J. LoumeauChief Legal Officer | Sell | -2,305 | $21.81 | $50 K | 3,240 | Form 4 |
| filed | Daniel FagaCEO, Director | Sell | -6,866 | $21.81 | $150 K | 898,027 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell | -2,554 | $21.81 | $56 K | 10,118 | Form 4 |
| filed | Dennis MulroyChief Financial Officer | Option exercise | +5,245 | — | — | 6,209 | Form 4 |
| filed | Eric J. LoumeauChief Legal Officer | Option exercise | +5,545 | — | — | 5,545 | Form 4 |
| filed | Daniel FagaCEO, Director | Option exercise | +17,850 | — | — | 904,893 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise | +6,145 | — | — | 12,672 | Form 4 |
| filed | Eric J. LoumeauChief Legal Officer | Sell10b5-1 plan | -882 | $14.19 | $13 K | 0 | Form 4 |
| filed | Eric J. LoumeauChief Legal Officer | Sell10b5-1 plan | -3,895 | $19.32 | — | 882 | Form 4 |
| filed | Dennis MulroyChief Financial Officer | Sell10b5-1 plan | -3,895 | $19.32 | $75 K | 964 | Form 4 |
| filed | Dennis MulroyChief Financial Officer | Option exercise | +6,000 | — | — | 6,964 | Form 4 |
| filed | Eric J. LoumeauChief Legal Officer | Option exercise | +6,000 | — | — | 6,882 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Option exercise | +6,000 | — | — | 8,632 | Form 4 |
| filed | Dennis MulroyChief Financial Officer | Sell | -2,105 | $19.48 | $41 K | 4,859 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Sell | -2,105 | $19.48 | — | 6,527 | Form 4 |
| filed | Eric J. LoumeauChief Legal Officer | Sell | -2,105 | $19.48 | — | 4,777 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Sell10b5-1 plan | -523 | $25.00 | $13 K | 0 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Option exercise | +2,500 | $14.02 | $35 K | 3,023 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Sell10b5-1 plan | -2,500 | $24.00 | $60 K | 523 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Sell10b5-1 plan | -1,146 | $20.50 | $23 K | 523 | Form 4 |
| filed | EcoR1 Capital, LLC10% owner | Buyindirect | +668,237 | $21.63 | $14.5 M | 7.52 M | Form 4 |
| filed | EcoR1 Capital, LLC10% owner | Sellindirect | -668,237 | $21.63 | $14.5 M | 7.52 M | Form 4 |
| filed | Daniel FagaInterim CEO, Director | Grant or award | +887,043 | — | — | 887,043 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +36,645 | $1.120 | — | 105,245 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -11,915 | $34.89 | $416 K | 93,330 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -19,208 | $35.75 | $687 K | 74,122 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -5,522 | $36.40 | $201 K | 68,600 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Grant or award | +523 | $22.03 | $12 K | 523 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Grant or award | +964 | $22.03 | $21 K | 68,600 | Form 4 |
| filed | Dennis MulroyChief Financial Officer | Grant or award | +964 | $22.03 | $21 K | 964 | Form 4 |
| filed | Paul F. LizzulChief Medical Officer | Grant or award | +964 | $22.03 | $21 K | 964 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +14,302 | $1.120 | — | 81,938 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -14,302 | $35.00 | $501 K | 67,636 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Option exercise | +2,500 | $14.02 | $35 K | 2,500 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +6,059 | $1.120 | — | 73,695 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Option exercise | +2,500 | $20.16 | $50 K | 5,000 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -6,059 | $35.00 | $212 K | 67,636 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Sell10b5-1 plan | -5,000 | $35.00 | $175 K | 0 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +36,646 | $1.120 | — | 104,282 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -34,087 | $32.27 | $1.1 M | 70,195 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -2,559 | $32.88 | $84 K | 67,636 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +15,993 | $1.120 | — | 83,629 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -15,993 | $30.00 | $480 K | 67,636 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +10,000 | $1.120 | — | 67,636 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +10,000 | $1.120 | — | 57,636 | Form 4 |
| filed | Oleg NodelmanDirector, 10% owner | Buyindirect | +165,000 | $23.25 | $3.8 M | 7.52 M | Form 4 |
| filed | Oleg NodelmanDirector, 10% owner | Buyindirect | +20,800 | $23.31 | $485 K | 7.36 M | Form 4 |
| filed | Oleg NodelmanDirector, 10% owner | Buyindirect | +35,700 | $23.16 | $827 K | 7.33 M | Form 4 |
| filed | Oleg NodelmanDirector, 10% owner | Buyindirect | +33,800 | $23.82 | $805 K | 7.30 M | Form 4 |
| filed | Oleg NodelmanDirector, 10% owner | Buyindirect | +13,900 | $23.80 | $331 K | 7.27 M | Form 4 |
| filed | Oleg NodelmanDirector, 10% owner | Buyindirect | +99,600 | $23.54 | $2.3 M | 7.25 M | Form 4 |
| filed | EcoR1 Capital, LLC10% owner | Buyindirect | +531,000 | $18.70 | $9.9 M | 7.15 M | Form 4 |
| filed | EcoR1 Capital, LLC10% owner | Buyindirect | +2.78 M | $18.97 | $52.7 M | 6.62 M | Form 4 |
| filed | EcoR1 Capital, LLC10% owner | Buyindirect | +29,500 | $25.48 | $752 K | 3.84 M | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Option exercise | +10,000 | $14.02 | $140 K | 10,000 | Form 4 |
| filed | Eric J. LoumeauCOO, General Counsel | Sell | -10,000 | $35.00 | $350 K | 0 | Form 4 |
| filed | James N. TopperDirector | Otherindirect | -973,612 | — | — | 0 | Form 4 |
| filed | James N. TopperDirector | Otherindirect | -344,860 | — | — | 700,171 | Form 4 |
| filed | James N. TopperDirector | Otherindirect | -98,275 | — | — | 199,529 | Form 4 |
| filed | James N. TopperDirector | Other | +22,604 | — | — | 54,458 | Form 4 |
| filed | James N. TopperDirector | Other | +26,354 | — | — | 80,812 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +10,000 | $1.120 | $11 K | 47,636 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +10,000 | $1.120 | $11 K | 37,636 | Form 4 |
| filed | J. Anthony WareDirector | Buy | +3,600 | $14.05 | $51 K | 3,600 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Option exercise | +46,202 | $6.930 | $320 K | 68,579 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +10,000 | $1.120 | — | 27,636 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -8,540 | $72.64 | $620 K | 31,524 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -6,440 | $73.70 | $475 K | 25,084 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -5,000 | $74.68 | $373 K | 20,084 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -1,994 | $75.86 | $151 K | 18,090 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -454 | $76.31 | $35 K | 17,636 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Option exercise | +10,060 | $0.700 | — | 32,437 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -6,009 | $72.45 | $435 K | 26,428 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -2,048 | $73.43 | $150 K | 24,380 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -2,003 | $74.50 | $149 K | 22,377 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +10,000 | $1.120 | — | 40,064 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Option exercise10b5-1 plan | +19,075 | $6.930 | $132 K | 41,452 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -4,181 | $69.29 | $290 K | 37,271 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -14,894 | $70.04 | $1.0 M | 22,377 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise10b5-1 plan | +40,000 | $1.120 | — | 70,064 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -27,760 | $70.65 | $2.0 M | 42,304 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -12,240 | $71.10 | $870 K | 30,064 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Gift | -122,500 | — | — | 22,377 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Option exercise10b5-1 plan | +8,048 | $0.700 | — | 152,925 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Option exercise10b5-1 plan | +22,000 | $6.930 | $152 K | 174,925 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -12,120 | $65.36 | $792 K | 162,805 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -3,185 | $66.38 | $211 K | 159,620 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -8,002 | $67.57 | $541 K | 151,618 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Sell10b5-1 plan | -6,741 | $68.47 | $462 K | 144,877 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise10b5-1 plan | +41,728 | $1.120 | — | 71,792 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -24,844 | $68.89 | $1.7 M | 46,948 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -9,084 | $69.68 | $633 K | 37,864 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -7,800 | $70.51 | $550 K | 30,064 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise10b5-1 plan | +30,000 | $1.120 | — | 60,064 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -12,003 | $71.11 | $854 K | 48,061 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -9,673 | $71.92 | $696 K | 38,388 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -8,324 | $72.88 | $607 K | 30,064 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -4,998 | $70.83 | $354 K | 30,064 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise10b5-1 plan | +30,587 | $1.120 | — | 65,649 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -15,276 | $70.57 | $1.1 M | 50,373 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -10,347 | $71.49 | $740 K | 40,026 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Sell10b5-1 plan | -4,964 | $72.48 | $360 K | 35,062 | Form 4 |
| filed | Dominic PiscitelliChief Financial Officer | Option exercise10b5-1 plan | +37,000 | $11.34 | $420 K | 37,000 | Form 4 |
| filed | Dominic PiscitelliChief Financial Officer | Sell10b5-1 plan | -3,554 | $70.34 | $250 K | 33,446 | Form 4 |
| filed | Dominic PiscitelliChief Financial Officer | Sell10b5-1 plan | -18,604 | $71.33 | $1.3 M | 14,842 | Form 4 |
| filed | Dominic PiscitelliChief Financial Officer | Sell10b5-1 plan | -4,820 | $72.24 | $348 K | 10,022 | Form 4 |
| filed | Dominic PiscitelliChief Financial Officer | Sell10b5-1 plan | -2,298 | $73.18 | $168 K | 7,724 | Form 4 |
| filed | Dominic PiscitelliChief Financial Officer | Sell10b5-1 plan | -6,624 | $74.33 | $492 K | 1,100 | Form 4 |
| filed | Dominic PiscitelliChief Financial Officer | Sell10b5-1 plan | -1,100 | $75.81 | $83 K | 0 | Form 4 |
| filed | Marco LondeiChief Medical Officer | Option exercise | +142,857 | $0.700 | — | 144,877 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +1,428 | $2.240 | — | 28,854 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +6,208 | $1.610 | — | 35,062 | Form 4 |
| filed | Hamza SuriaPresident, CEO, Director | Option exercise | +22,428 | $2.590 | — | 27,426 | Form 4 |
| filed | Nader J. Naini10% owner | Otherindirect | -1.37 M | — | — | 973,612 | Form 4 |
| filed | Nader J. Naini10% owner | Other | -1.37 M | — | — | 973,612 | Form 4 |
| filed | James N. TopperDirector | Otherindirect | -1.37 M | — | — | 973,612 | Form 4 |
| filed | James N. TopperDirector | Otherindirect | +301,024 | — | — | 301,024 | Form 4 |
| filed | James N. TopperDirector | Otherindirect | -301,024 | — | — | 0 | Form 4 |
| filed | James N. TopperDirector | Other | +31,854 | — | — | 31,854 | Form 4 |
| filed | Nicholas LydonDirector | Sell10b5-1 plan | -2,600 | $84.18 | $219 K | 301,506 | Form 4 |
| filed | Nicholas LydonDirector | Sell10b5-1 plan | -10,310 | $85.11 | $877 K | 291,196 | Form 4 |
| filed | Nicholas LydonDirector | Sell10b5-1 plan | -1,390 | $86.15 | $120 K | 289,806 | Form 4 |
| filed | Nicholas LydonDirector | Sell10b5-1 plan | -9,425 | $87.46 | $824 K | 280,381 | Form 4 |
| filed | Nicholas LydonDirector | Sell10b5-1 plan | -4,250 | $88.30 | $375 K | 276,131 | Form 4 |
| filed | Nicholas LydonDirector | Sell10b5-1 plan | -2,803 | $89.42 | $251 K | 273,328 | Form 4 |
| filed | Nicholas LydonDirector | Sell10b5-1 plan | -2,222 | $90.26 | $201 K | 271,106 | Form 4 |
| filed | Nicholas LydonDirector | Option exercise | +16,483 | $4.550 | $75 K | 304,106 | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -356,300 | $21.10 | $7.5 M | 1.94 M | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -143,428 | $21.00 | $3.0 M | 2.29 M | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -35,172 | $21.79 | $766 K | 2.44 M | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -480,000 | $21.10 | $10.1 M | 2.47 M | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -1,023 | $22.92 | $23 K | 2.47 M | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -10,271 | $22.00 | $226 K | 2.95 M | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -21,451 | $22.01 | $472 K | 2.96 M | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -25,700 | $23.87 | $613 K | 2.98 M | Form 4 |
| filed | Novo Holdings A/S10% owner | Sell | -23,555 | $23.87 | $562 K | 3.01 M | Form 4 |
| filed | Stephen Lawrence Tomlin10% owner | Otherindirect | -399,987 | — | — | 1.64 M | Form 4 |
| filed | Stephen Lawrence Tomlin10% owner | Otherindirect | +37,040 | — | — | 37,040 | Form 4 |
| filed | Stephen Lawrence Tomlin10% owner | Sellindirect | -37,040 | $24.35 | $902 K | 0 | Form 4 |
| filed | Alan D. Frazier10% owner | Exercise of in-the-money derivative | +117,235 | $4.550 | $533 K | 2.35 M | Form 4 |
| filed | Nathan R. Every10% owner | Exercise of in-the-money derivativeindirect | +117,235 | $4.550 | $533 K | 2.35 M | Form 4 |
| filed | A/s Novo10% owner | Conversion | +1.43 M | — | — | 1.43 M | Form 4 |
| filed | A/s Novo10% owner | Conversion | +486,820 | — | — | 1.92 M | Form 4 |
| filed | A/s Novo10% owner | Conversion | +312,986 | — | — | 2.23 M | Form 4 |
| filed | A/s Novo10% owner | Conversion | +673,454 | — | — | 2.90 M | Form 4 |
| filed | A/s Novo10% owner | Exercise of in-the-money derivative | +81,673 | — | — | 2.98 M | Form 4 |
Source: SEC Forms 4 and 5. A trade under a 10b5-1 plan was scheduled in advance. For information only; not investment advice